Biomarkers and Biosimilars in Diabetes


Biosimilars are biological medical products/molecules which are almost identical copies of an original product manufactured by different companies and an already FDA-approved biological product, referred to as a reference product.  Human bio monitoring (HBM) is a tool of health-related environmental monitoring.



Diabetes is a major lifestyle disease, It is necessary to identify potential biomarkers associated with diabetes for early detection and proper management of diabetes.  Biomarkers are known as signature molecules or molecular markers or biological molecules found in blood, tissues and other body fluids. Biomarkers are used to monitor how well the body is responding to a particular disease. Hemoglobin A1c is considered as a biomarker for the presence of Diabetes Mellitus biosimilars in diabetes.



 


  • Scope and Role of Biomarkers
  • Biomarker Application in diabetes research
  • Novel Biomarkers
  • Biosimilar Development, Review, and Approval
  • Biosimilar and Interchangeable Products
  • Prescribing Biosimilar and Interchangeable Products
  • Biosimilar Product Information

Related Conference of Biomarkers and Biosimilars in Diabetes

March 17-18, 2021

30th European Diabetes Congress

Barcelona, Spain
April 13-14, 2021

World congress on Endocrinology and Metabolic syndrome

Auckland, Newzealand
May 10-11, 2021

30th World Diabetes & Heart Congress

Singapore, Singapore
June 16-17, 2021

World Summit on Diabetes

Rome, Italy
June 23-24, 2021

Virtual event on Obesity and Hormones

Rome, Italy
September 02-03, 2021

5th Annual Congress on Diabetes, Obesity and Its Complications

Vienna, Australia
September 20-21, 2021

15th European Diabetes and Endocrinology Congress

London, UK
September 23-24, 2021

20th International Conference on Obesity

Paris, France
October 14-15, 2021

Global congress on Endocrinology and Gynecology

Sydney, Australia
October 18-19, 2021

2nd Annual Summit on Diabetes and Endocrinology

Paris, France
October 28-29, 2021

2nd Global summit on Diabetes and Endocrinology

Amsterdam, Netherlands
November 16-17, 2021

World congress and Expo on Diabetes

Osaka, Japan
November 16-17, 2021

World congress and Expo on Diabetes

Osaka, Japan
December 07-08, 2021

13th World Congress on Endocrinology and Metabolic Disorders

Auckland, Newzealand

Biomarkers and Biosimilars in Diabetes Conference Speakers

Recommended Sessions

Related Journals

Are you interested in